Navigation Links
sell in Biological Technology

Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward

PRINCETON, N.J., July 15 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced it has signed an agreement to sell its Interactive Voice & Web Response Services (IVRS/IWRS) business to Phase Forward (Nasdaq: PFWD ). In addition, Covance and Phase Forward have agree...

Delcath Enters Agreement to Sell 869,565 Units

NEW YORK, June 10 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary Percutaneous Hepatic Perfusion (PHP(TM)) System for the treatment of cancers of the liver, today announced that it has entered into a definitive agreement to se...

VisualSonics to Sell Mauna Kea Technologies' Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market

PARIS and TORONTO, March 31 /PRNewswire/ - Mauna Kea Technologies and VisualSonics today announced that they have entered an exclusive distribution agreement through which VisualSonics will market and sell Cellvizio LAB high resolution in vivo imaging systems to pre-clinical researchers on a world...

Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the People's Republic of China

HANGZHOU, China and CARSON CITY, Nev., March 10 /PRNewswire-FirstCall/ -- Niusule Biotech Corp. (OTC Bulletin Board: NIUS) announces that its new Venture, Niusule Bioengineering (Hangzhou) Co., Ltd., has been formally established by obtaining the "Certificate of Approval for Establishment of Enter...

Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million

CTI to focus on Pixantrone and OPAXIO Approval and Commercialization SEATTLE, Feb. 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it exercised its option to sell its 50% ownership interest in the Zevalin joint venture to Spectrum Pharmac...

Pharmos Announces Agreement to Sell Certain CB2 Selective Agonists

ISELIN, N.J., Feb. 18 /PRNewswire-FirstCall/ -- Pharmos Corporation (Nasdaq: PARS ) announced today that it has entered into an agreement with an Israel based company, Reperio Pharmaceuticals Ltd. (Reperio) for the sale of the patent rights and technical know how related to the compound known as...

Multisol France on Track to Sell 250 Tons of International Fuel Technology, Inc. Fuel Additive Formulations

Multisol France realizes recurring revenue from the sale of International Fuel Technology, Inc. fuel additive formulations and is on track to sell over 250 tons of it during the first year of its distribution agreement with IFT. St. Louis, MO (PRWEB) February 4, 2009 --...

AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners

All amounts are in U.S. dollars QUEBEC CITY, Nov. 12 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has signed a definitive agreement to sell to Cowen Healthcare ...

Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics

DUSSELDORF, Germany, August 1 /PRNewswire-FirstCall/ -- - Further Focus on Pharma & Life Science Gerresheimer AG is to discontinue its business in technical plastic systems. The business segment, which primarily manufactures system components for suppliers to the automobile industry, is no...

Protein Sciences Announces Termination of Deal to Sell to Emergent BioSolutions

- PSC terminates sale due to Emergent's breaches - PSC BLA for FluBlok remains on track with the FDA - PSC awaiting decision on BARDA contract award MERIDEN, Conn., July 29 /PRNewswire/ -- Protein Sciences Corporation ("PSC") announced today that the sale of its...

InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions

ROCKVILLE, Md. and NEWTON, Mass., April 17 /PRNewswire-FirstCall/ -- InforMedix Holdings, Inc. (OTC Bulletin Board: IFMX), providing Med-ePhone(TM), Med-eMonitor(TM), and Med-eXpert(TM) Systems to improve medication adherence and health status monitoring, and InnovationRx, a provider of prescr...

diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test

SOUTH SAN FRANCISCO, Calif., April 15 /PRNewswire/ -- diaDexus, Inc. today announced the appointment of Fisher HealthCare as the exclusive customer channel for its new automated PLAC Test for the Hitachi, Hitachi Roche P-Modular and Olympus chemistry analyzers to U.S. hospital clinical laborat...

ActivBiotics Set to Sell Proprietary Assets, Including Drug Product Candidates, on March 14, 2008

WELLESLEY HILLS, Mass., March 5 /PRNewswire/ -- Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, confirmed today that the sale of ActivBiotics' proprietary assets will be carried out through a sealed bid at 12:00 PM on March 14, 2008. There has been substant...

CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)

The HemeScan(TM) Test Provides Prognostic Marker Precision and Simultaneous Diagnostic Monitoring MUKILTEO, Wash. and ALISO VIEJO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- CombiMatrix Corporation (Nasdaq: CBMX ) and Clarient, Inc. (Nasdaq: CLRT ) today jointly ann...

Olympus Capital Announces Agreement to Sell Arysta LifeScience Corporation

TOKYO, Oct. 22 /Xinhua-PRNewswire/ -- Olympus Capital Holdings Asia and its co-investors today announced that they have reached an agreement to sell Arysta LifeScience Corporation, the world's largest privately held crop- protection and life-science company, for an enterprise value of approxim...

Australian company will sell TeraMedica's medical imaging software

Magnetic resonance image of a hand. Source: Kemie Guaida. MILWAUKEE -- TeraMedica has announced that Australian-based Intelligent Image Management will license its software for managing data from health care imaging systems. TeraMedica's Intelligent Image Manager, or TI2m software, on whic...

GenTel will sell Dutch firm's biomolecule labeling technology

Madison, Wis. -- GenTel BioSurfaces, Inc., of Madison has been licensed to sell a Dutch company's non-enzymatic labeling technology for biomolecules and labeling agents, GenTel announced on Tuesday. GenTel will market and sell the Universal Linkage System labeling reagents of Kreatech Biote...

Serigraph will manufacture, sell RFID system

West Bend, Wis. - Serigraph Inc. will manufacture, market and sell radio frequency identification (RFID) labels, seals and tags through a licensing agreement with MIKOH Corp. of Sydney, Australia. MIKOH's Smart&Secure technology disables an RFID tag if it is interfered with after its origi...

Journal to sell Norlight Telecommunications

Milwaukee, Wis. - Seven months after Journal Communications announced plans to spin off Norlight Telecommunications to its shareholders, the company has instead decided to sell Norlight to the Indiana-based Q-Comm Corp. for $185 million. Q-Comm and Journal Communications have signed a defi...

TomoTherapy to sell medical devices in India

Madison, Wis. - TomoTherapy executives have talked about their interest in expanding geographically, and now their plans are bearing fruit. The Madison-based medical technology company has announced that it is partnering with Kirloskar Theratronics, Ltd . to distribute its TomoTherapy Hi-A...

A disgusting video: U.S. companies sell out Americans

If you thought some of the CEOs caught up in the scandals of WorldCom, ENRON, and TYCO were heartless and greedy, watch this video from Cohen & Grigsby . The people on this video make them look like saints. Why? Because the people on the video have no regard for people trying to make a living to...

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

...armaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has agreed to sell an aggregate of four million shares of its common stock at a price to the p... www.sec.gov . This communication shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...enue derived from royalties paid to us by partners that develop, market and sell products incorporating certain of our proprietary technologies. Currently, ...echnology and products; our ability to successfully manufacture, market and sell our products; the availability of capital to finance our activities; our ab...

ADVENTRX Pharmaceuticals Announces Financing

... Group, Inc. (Nasdaq: RODM ), acted as the exclusive placement agent for the transaction. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

...to the offering. Leerink Swann LLC is acting as sole book-running manager for the offering. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Idenix, nor shall there be any sale of securities in any state or jurisdiction in which such ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...ed or closed during the second quarter of 2009, the loss on divestment of Jerini's Peptides business and the write-off of the fair value less costs to sell of assets previously classified as held for sale. FINANCIAL INFORMATION TABLE OF CONTENTS ...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

...atement that was declared effective by the Securities and Exchange Commission on June 2, 2009. This will allow Poniard from time to time to offer and sell up to $60 million aggregate amount of its common stock and warrants. Second Quarter 2009 Unaudited Financial Results The Company ...

Micromet Closes $80.5 Million Public Offering of Common Stock

...manager with RBC Capital Markets and Merriman Curhan Ford as co-managers in this offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solic...

Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures

...ommercialization of our technology and products; market acceptance of our technology and products; our ability to successfully manufacture, market and sell our products; the continued availability of capital to finance our activities; and any other factors referenced in our other filings with the Securiti...

Human Genome Sciences Announces Closing of Public Offering

...the offering. The shares were issued pursuant to an effective shelf registration statement. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Human Genome Sciences, Inc., nor shall there be any sale of securities in any state or jurisd...

Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores

... distributor sources successful, independently owned stores within their assigned territories that have typically been in existence for many years and sell a variety of agricultural input products. Yongye does not execute any direct agreements with the store owners and the distributors are responsible for...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...ication (NDA). In the agreement announced today, Transcept has granted Purdue and a Purdue associated company an exclusive license to market, sell and distribute Intermezzo ((R) )in the United States and the right to negotiate for the commercialization of the product in Canada and Mexico. Transc...

CuraGen Reports Second Quarter 2009 Financial Results

...t becomes available. This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be a...

TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction

...ddresses above. This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be a...

Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing

... Pursuant to the respective purchase agreements, Senesco will issue and sell (i) up to 783,332 shares of its common stock (the "Shares") at a price of $...nt Information This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of thes...

Micromet Announces Pricing of Public Offering of Common Stock

...ement relating to the offering will be filed with the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solic...

Cornerstone Therapeutics Announces Closing of Chiesi Transaction

...ence on the commercial success of a relatively small number of currently marketed products; our ability to maintain regulatory approvals to market and sell our products that do have FDA-approved marketing applications; our ability to enter into additional strategic licensing, collaboration or co-promotion...

Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation

...emcitabine hydrochloride around the world. As part of the settlement, Lilly has granted ScinoPharm a royalty bearing license to manufacture and sell gemcitabine hydrochloride (API) throughout the world, excluding only countries where the Lilly compound or method of use patents remain in force and t...

Micromet Announces Public Offering of Common Stock

...lement relating to the offering will be filed with the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solic...

BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol

...ing Verenium's technologies and timing for launching any commercial products and projects, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to...
Other Tags
(Date:7/25/2014)... a molecular testing panel developed at UPMC greatly ... surgery for patients with thyroid nodules and cancer, ... Institute (UPCI), partner with UPMC CancerCenter., The test, ... other diagnostic testing agencies, improved the chances of ... percent, according to the study published this month ...
(Date:7/25/2014)... , July 25, 2014 ... consumers are turning to digital technology for online & ... NXTD), Google Inc. (NASDAQ: GOOG ), LifeLock ... V ), Apple Inc. (NASDAQ: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused ...
(Date:7/24/2014)... sobering examples of how wildlife loss leads to conflict ... by Wildlife Conservation Society (WCS) Health & Ecosystems: ... calls for an interdisciplinary approach to tackle global biodiversity ... about 15% of the world,s people and provides protein ... It should come as no surprise that today,s unprecedented ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6New study draws links between wildlife loss and social conflicts 2
(Date:7/25/2014)... Progress in understanding the molecular genetics of brain ... brain tumor treatments, according to Patrick Wen, MD, professor ... for Neuro-Oncology, Dana-Farber Cancer Institute. , At the American ... in Chicago, July 25-26, Dr. Wen will moderate a ... the development of new treatments and advancing strategies to ...
(Date:7/25/2014)... San Jose, CA (PRWEB) July 25, 2014 ... MaaS360 WorkPlace Partner Program . Splashtop Business and ... MaaS360 Market, and will leverage the MaaS360 WorkPlace ... corporate data. , Splashtop Business and Splashtop Enterprise offer ... using any device. High performance, ease of ...
(Date:7/25/2014)... July 25, 2014 Garth Brooks Chicago ... the Allstate Arena in Rosemont. Garth Brooks was one of ... released his first single in 1989. Since "Much Too Young (To ... the shows from the Tulsa, Okl. native and in the years ... see him back on a stage and in the recording studio. ...
(Date:7/25/2014)... be treated more quickly after Manchester research , ... blood test on arrival, is effective in reducing ... study shows., The findings of a research group ... could potentially make a huge difference to a ... most common reason for emergency hospital admission. In ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Ross A. ... has been invited to join the exclusive Obagi Clinical ... leading facial plastic surgeons, plastic surgeons and dermatologists. ... this exclusive Advisory Board of thought leaders held its ... the meeting was to give Obagi the opportunity to ...
Breaking Medicine News(10 mins):Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 2Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 4Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 2Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 3Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 4Health News:Garth Brooks Chicago Tickets for Performance at Allstate Arena in Rosemont Go On Sale July 25th 2Health News:Garth Brooks Chicago Tickets for Performance at Allstate Arena in Rosemont Go On Sale July 25th 3Health News:Heart attack patients could be treated more quickly after Manchester research 2Health News:Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board 2
Other Contents